However, it is not yet known if ApoER2-Dab1 pathway disruption plays a role in amygdala degeneration in MCI and AD, or whether accumulation of ApoER2 pathway components correlates with cognitive or neuropsychiatric endpoints. The gene discussed is DAB1; the disease is Alzheimer disease.